NasdaqGM - Delayed Quote • USD
MediciNova, Inc. (MNOV)
At close: April 25 at 4:00 PM EDT
After hours: April 25 at 6:30 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -0.05 | -0.06 | -0.23 | -0.24 |
Low Estimate | -0.05 | -0.06 | -0.23 | -0.24 |
High Estimate | -0.05 | -0.06 | -0.23 | -0.24 |
Year Ago EPS | -0.07 | -0.06 | -0.17 | -0.23 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | 1M | -- |
Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -0.07 | -0.07 | -0.08 | -0.08 |
EPS Actual | -0.07 | -0.06 | -0.01 | -0.04 |
Difference | 0 | 0.01 | 0.07 | 0.04 |
Surprise % | 0.00% | 14.30% | 87.50% | 50.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.05 | -0.06 | -0.23 | -0.24 |
7 Days Ago | -0.05 | -0.06 | -0.23 | -0.24 |
30 Days Ago | -0.05 | -0.06 | -0.23 | -0.24 |
60 Days Ago | 0 | 0 | -0.32 | -0.35 |
90 Days Ago | 0 | 0 | -0.32 | -0.35 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | MNOV | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 28.60% | -- | -- | 2.60% |
Next Qtr. | 0.00% | -- | -- | 13.40% |
Current Year | -35.30% | -- | -- | 5.20% |
Next Year | -4.30% | -- | -- | 13.30% |
Next 5 Years (per annum) | 20.00% | -- | -- | 11.11% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Initiated | Maxim Group: Buy | 3/10/2021 |
Maintains | B. Riley Securities: Buy | 3/13/2020 |
Initiated | B. Riley Securities: Buy | 3/28/2018 |
Maintains | Ladenburg Thalmann: Buy | 5/24/2012 |
Related Tickers
KZR Kezar Life Sciences, Inc.
0.7900
-1.42%
ACOGF Alpha Cognition Inc.
0.4950
+0.45%
INAB IN8bio, Inc.
1.0400
-1.89%
CNTB Connect Biopharma Holdings Limited
1.3600
-2.16%
ATHA Athira Pharma, Inc.
1.9200
-4.48%
ALVR AlloVir, Inc.
0.8000
+2.56%
RIGL Rigel Pharmaceuticals, Inc.
1.1000
-2.22%
VRPX Virpax Pharmaceuticals, Inc.
2.9184
-5.55%
LYEL Lyell Immunopharma, Inc.
2.2000
-4.35%
IMTX Immatics N.V.
9.78
-3.65%